Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 7/20 | 0.71 |
| ▸ | THRA | P10827 | 5/20 | 0.71 |
| ▸ | PPARG | P37231 | 4/20 | 0.71 |
| ▸ | RXRA | P19793 | 3/20 | 0.71 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.71 |
| ▸ | ITGAV | P06756 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | PGR | P06401 | 2/20 | 0.51 |
| ▸ | HTR1A | P08908 | 2/20 | 0.51 |
| ▸ | HTR2B | P41595 | 2/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7643075 | 0.86 | THRB (0.57) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL5012985 | 0.86 | THRA (0.60) | THRBTHRAPPARGRXRAITGB3 | |
| Tetrac SCHEMBL365951 | 0.84 | THRB (1.00) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL1527125 | 0.83 | ERN1 (0.55) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL5928042 | 0.83 | THRB (0.53) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL30448708 | 0.80 | THRA (0.51) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL378767 | 0.80 | THRA (0.51) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL10962553 | 0.80 | THRB (0.50) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL12837302 | 0.79 | THRB (0.89) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL12837223 | 0.79 | THRB (0.83) | THRBTHRAPPARGRXRAITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030983-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-07-09 | — | — | US | disclosed |
| EP-3394024-B1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | UNIV RUTGERS (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230167238-A1 | POLYMETRIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-06-01 | — | — | US | disclosed |
| US-11649203-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-05-16 | — | — | US | disclosed |
| US-20220002478-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2022-01-06 | — | — | US | disclosed |
| US-11124603-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-09-21 | — | — | US | disclosed |
| WO-2021163520-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-08-19 | — | — | WO | disclosed |
| US-20200369597-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2020-11-26 | — | — | US | disclosed |
| US-10774030-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2020-09-15 | — | — | US | disclosed |
| EP-3312155-B1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | UNIV RUTGERS (US) | 2020-08-05 | — | — | EP | disclosed |
| EP-3394024-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | Rutgers, The State University of New Jersey (US) | 2018-10-31 | — | — | EP | disclosed |
| EP-3312155-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | Rutgers, The State University of New Jersey (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-2809702-B1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | UNIV RUTGERS (US) | 2017-12-20 | — | — | EP | disclosed |
| WO-2017111994-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-06-29 | — | — | WO | disclosed |
| US-20160376401-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2016-12-29 | — | — | US | disclosed |
| US-9416090-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-08-16 | — | — | US | disclosed |
| US-20130203713-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-08-08 | — | — | US | disclosed |
| EP-0802798-A1 | METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS | CHIRON CORPORATION (US) | 1997-10-29 | — | — | EP | disclosed |
| WO-1995022992-A1 | METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS | CHIRON CORPORATION (US) | 1995-08-31 | — | — | WO | disclosed |
| US-5273885-A | Using a polyiodothyronine analog of a phenyl compound containing a hydroxyl group ortho to an iodine | SYNTEX (U.S.A.) INC. (US) | 1993-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130203713-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | TH, TYR, MYB | THRB 3226/4885THRA 2566/4885PPARG 1129/4885 |
| US-12030983-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | TH, TYR, MYB | THRB 3084/4885THRA 2478/4885PPARG 1026/4885 |
| US-11124603-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | TH, TYR, MYB | THRB 3226/4885THRA 2566/4885PPARG 1129/4885 |
| US-20220002478-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | TH, TYR, MYB | THRB 3084/4885THRA 2478/4885PPARG 1026/4885 |
| US-10774030-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | TH, TYR, HPD | THRB 1124/4885THRA 778/4885PPARG 2682/4885 |
| US-20200369597-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | TH, TYR, TYRO3 | THRB 1884/4885THRA 1319/4885PPARG 2712/4885 |
| US-20160376401-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | TH, TYR, MYB | THRB 3226/4885THRA 2566/4885PPARG 1129/4885 |
| US-11649203-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | TH, TYR, TYRO3 | THRB 1884/4885THRA 1319/4885PPARG 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.